SAT-377 CRISPR-Cas13b-mediated suppression of hepatitis B surface antigen-pre-clinical investigations of a new therapeutic approach von McCoullough, Laura, Fareh, Mohamed, Hu, Wenxin, Sozzi, Vitina, Makhlouf, Christina, Droungas, Yianni, Lee, Chee Leng, Netter, Hans, Takawy, Mina, Lewin, Sharon, Purcell, Damian, Holmes, Jacinta, Trapani, Joseph, Littlejohn, Margaret, Revill, Peter

Volltext

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression von McCoullough, Laura C., Fareh, Mohamed, Hu, Wenxin, Sozzi, Vitina, Makhlouf, Christina, Droungas, Yianni, Lee, Chee Leng, Takawy, Mina, Fabb, Stewart A., Payne, Thomas J., Pouton, Colin W., Netter, Hans J., Lewin, Sharon R., Purcell, Damian FJ, Holmes, Jacinta A., Trapani, Joseph A., Littlejohn, Margaret, Revill, Peter A.

Volltext

Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia von Goossens, Steven, Peirs, Sofie, Van Loocke, Wouter, Wang, Jueqiong, Takawy, Mina, Matthijssens, Filip, Sonderegger, Stefan E., Haigh, Katharina, Nguyen, Thao, Vandamme, Niels, Costa, Magdaline, Carmichael, Catherine, Van Nieuwerburgh, Filip, Deforce, Dieter, Kleifeld, Oded, Curtis, David J., Berx, Geert, Van Vlierberghe, Pieter, Haigh, Jody J.

Volltext